|
Board of Natco Pharma recommends interim dividend> |
|
National Aluminium Company Ltd leads losers in 'A' group> |
|
Natco Pharma to convene board meeting> |
|
NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets> |
|
Natco Pharma completes acquisition of additional 13.25% stake in Adcock Ingram> |
|
NATCO Pharma, Lupin secure USFDA approval for Eribulin Mesylate injection> |
|
Lupin and alliance partner Natco receive USFDA approval for Eribulin Mesylate Injection> |
|
Natco Pharma consolidated net profit declines 34.11% in the March 2026 quarter> |
|
Natco Pharma tanks after Q4 profit declines 34% YoY to Rs 268 cr> |
|
Natco Pharma Ltd leads losers in 'A' group> |